Discover how Climb is transforming Non-GLP study management for preclinical research teams.
Non-GLP studies that support regulatory safety decisions are required by the FDA to be submitted in SEND, regardless of GLP status. Data collected in Climb™ can be efficiently converted into submission-ready SEND using Instem’s Submit™...
Discover how a leading organization transformed its preclinical research with Instem’s digital R&D lab execution system. This case study highlights how digitization streamlined lab operations, improved data accuracy, and accelerated study timelines.
In vivo research is essential for new therapeutics, but minimizing animal burden is key. Instem’s Climb software helps ensure ethical research by supporting the principles of Reduction, Refinement, and Replacement.
Researchers can boost efficiency in non-GLP work by adopting a structured approach using a dedicated, pathologist-driven system like Provantis.
Discover the key advantages of total quality management (TQM) and how it helps businesses improve efficiency, enhance quality, and achieve long-term success.
